about
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionChanges in sexual risk behavior among MSM participating in a research cohort in coastal Kenya.Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological ProfilesPrevalence and determinants of insufficient work ability in older HIV-positive and HIV-negative workersFemale sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohortDrug users in Amsterdam: are they still at risk for HIV?Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous ClearancePrevalence, determinants and genetic diversity of hepatitis C virus in the multi-ethnic population living in Suriname.Do sexual risk behaviour, risk perception and testing behaviour differ across generations of migrants?HIV transmission patterns among The Netherlands, Suriname, and The Netherlands Antilles: a molecular epidemiological study.Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs.Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesPrevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.Development and validation of a risk score to assist screening for acute HIV-1 infection among men who have sex with menSpontaneous Clearance of Hepatitis C Virus Infection Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men.Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM).The association between ethnicity and vaginal microbiota composition in Amsterdam, the NetherlandsReasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study.Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitisColonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam.The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women.HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infectionPrognostic factors for important clinical outcomes in patients with a severe infection.Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010.Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior.Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) studyIs adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men.People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands.Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.Is anyone around me using condoms? Site-specific condom-use norms and their potential impact on condomless sex across various gay venues and websites in The NetherlandsSex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras.Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands - the HELIUS study.Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyCost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the NetherlandsA longitudinal study on determinants of HPV vaccination uptake in parents/guardians from different ethnic backgrounds in Amsterdam, the Netherlands
P50
Q27014761-F9BADAF8-6CAC-46E7-BC21-D18EE23685C3Q27313429-955374A5-3B73-4B90-92AA-C023EAA8F196Q27490460-F838CDDE-324C-44F2-A58F-D25FF03A43F5Q28391933-3B0E8EBB-4DF5-4A7D-BCDE-BFA780BB323FQ28477975-5B720011-B688-4361-A5FC-FF23613CB52CQ28488151-87B4E68E-10F9-49A3-A498-9B4CEFF13C7DQ28552909-7093018D-2CB8-4EE0-81E8-E310BEA2312CQ29353552-7B30B933-2B79-445D-BE15-AE2623AE4F57Q29353749-7BDCA928-8773-462A-A908-BD5C842485AFQ29353841-88E373BB-CAFC-4D46-BB9E-4EDAAD1AD245Q30208996-0B9D3F56-BE92-445E-861C-1E7BACBFE25FQ30223906-D805C053-CE38-475E-B031-39892235B9E1Q30226978-B5D0A205-A8F6-467D-ABBF-EF9AF98F2288Q31018156-F781F9D2-766D-46CC-98F1-034B495D9FC4Q33590896-D44324DF-FD29-46CD-A594-E3FC4A86D796Q33801473-0590867E-8B3B-4FA2-9DA0-B667D6C969E9Q33806629-F9061B8B-8BF2-4F86-8E88-60F6E48FA5EEQ33822918-CE12EB2C-4F4C-4FD2-B528-901D216860E8Q33898250-32E8716F-5D7A-409D-9F07-C364FBF4B34AQ33898300-1B561D76-3B1A-4423-B987-90970213B7CCQ34260671-9907A931-65C6-4986-9B37-2C8FD173F5A0Q34264303-DE11368D-FCA1-4987-8D8D-B8030998601CQ34580254-9A0DA984-29BE-4989-A045-9CA604C83232Q34613207-EAD89D0A-71F4-416D-8E96-E4AB960942D3Q34619918-545DE5D5-DB1A-4BC1-B7B3-2D44C8AA7096Q34661893-B18F6550-7015-4258-AB18-7441B3F77323Q34727694-41CC0F8E-82A3-4D90-AEF5-3CE81ABD8929Q34785317-859E88F0-EDDD-4580-9B61-71AFC332B716Q34946693-5B0EB88B-F5DE-4486-8698-5E774B633AC6Q34991890-87B265C4-E434-4F9C-85A4-D64611D240BEQ35213999-F7889985-42A1-49E7-852E-169419F17E43Q35249648-7621CEC0-EB93-4A6A-ACAA-A5399CAF7CEDQ35834104-4F94ACF0-5C8E-4177-8875-CD7882723CC8Q35893684-C0EF0FA1-FB1A-4AFF-B35B-1C878BBADF17Q36063125-E2DAEEBD-5011-4184-99EF-3420CCA02A78Q36088744-978B616C-E5EF-42B7-B807-EB186B1AF8B6Q36141756-408058F1-353C-45A5-BF1D-07AB51B03CD0Q36148971-108A2378-CFD1-4CBB-BE65-91436C55EE28Q36155257-7AC10288-609F-4446-AF0C-52B2CDBA9046Q36286832-FDAD5751-9B3E-4D95-A4F3-8346D06F89FF
P50
name
Maria Prins
@en
type
label
Maria Prins
@en
prefLabel
Maria Prins
@en